Trials / Completed
CompletedNCT02977702
Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 114 (actual)
- Sponsor
- Institut de Cancérologie de Lorraine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study was to validate Total Psoas Area (TPA) measurement as an independent prognostic factor of overall survival in patients with pancreatic adenocarcinoma. Secondary objective was to describe the evolution of the TPA during the follow-up.
Conditions
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2016-11-30
- Last updated
- 2016-11-30
Source: ClinicalTrials.gov record NCT02977702. Inclusion in this directory is not an endorsement.